CMS Launches AI For Medicare Prior Authorization Across Six States
The Trump administration launches an AI-driven pilot program in six states to manage Medicare prior authorization, raising industry concerns over claim denials and AI incentives.
Congressional Opposition Mounts Against CMS Medicare Prior Authorization Expansion
Congresswoman Maggie Goodlander and colleagues urge CMS to halt the proposed expansion of prior authorization in Traditional Medicare, citing risks to patient care and administrative burdens.
CMS and Insurers Launch AI-Driven Medicare Prior Authorization Reforms
CMS introduces WISeR model using AI to expedite Medicare prior authorizations while insurers enhance processes to cut waste and improve care approval speeds.
Former U.S. Rep. Wexton Advances PSP Care Using AI Voice Tech, Spurs Legislation
Former U.S. Rep. Jennifer Wexton uses AI-generated voice tech to address PSP symptoms, advocates for Parkinson's legislation, impacting healthcare innovation and insurance compliance.
CCS AI Platform Enhances CGM Adherence, Saves Over $10M in Medicare Diabetes Care
CCS’s AI-driven PropheSee™ platform significantly improves CGM adherence in Medicare diabetes patients, saving $10M+ and advancing preventive chronic care.
Prior Authorization Reforms and AI: Transforming U.S. Healthcare Compliance in 2025
Explore the 2024 CMS prior authorization rule and the impact of AI on healthcare administrative processes, improving compliance and patient care timelines.
Reforming Medicare Coverage to Improve Access to Advanced Wound Care Therapies
Explore the impact of Medicare Administrative Contractors on coverage decisions for advanced wound care therapies and the potential of AI-driven reforms to improve patient access and reduce costs.
Advisory Board Insights Drive Healthcare Strategy Amid Industry Transformation
Explore how the Advisory Board supports healthcare leaders with insights and strategies on industry trends, FDA approvals, AI, and health equity shaping the U.S. insurance and healthcare sectors.
Reveleer Expands AI-Driven Value-Based Care Platform with Novillus Acquisition
Reveleer acquires Novillus to enhance its AI-driven value-based care platform, improving payer-provider collaboration, care gap closure, and clinical intelligence for health plans.
Nexalin Backing Senate Bill to Expand Medicare AI Device Reimbursement
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.